In person One of our ADS scientists, Welmoet de Winter will represent our team at the upcoming ELRIG Conference, where she will present the research of our team on site-selective screening and fragment-based drug discovery. Her poster: “Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14” focuses on the…
Developments in Protein Interaction Analysis (DiPIA 2026)
In person Our colleagues Henri van Son and Ronald Jean-Baptiste will represent ZoBio team at the DIPIA Conference hosted by Cytiva. This event brings together industry peers to share best practices, research, and new applications in the field. The conference is specifically dedicated to surface plasmon resonance (SPR) technology.. Henri and Ronald will present two…
16th Swiss Course on Medicinal Chemistry in Leysin
In person As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies…
Discovery on Target
In person ZoBio will participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small…